New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
16:27 EDTNKE, DD, FINL, MNKD, MTW, DG, AMEDOn The Fly: Closing Wrap
Stocks on Wall Street were higher after a late day rise allowed all of the major averages to end the week on a high note. The averages began the session in negative territory but soon turned mixed. The Nasdaq was able to hold its head above water for most of the session while the Dow struggled for most of the day under the weight of DuPont (DD) shares, which were down more than 3% after the company lowered its guidance. ECONOMIC EVENTS: In the U.S., the final University of Michigan consumer sentiment index for June rose to 82.5, which beat the consensus expectation for a reading of 81.9. COMPANY NEWS: Shares of athletic apparel and footwear giant Nike (NKE) and sports shoe retailer Finish Line (FINL) climbed after both companies reported better than expected quarterly sales and profits. Dow member Nike rose 82c, or 1.07%, to $77.68, while Finish Line advanced 41c, or 1.41%, to $29.56... Another member of the Dow Jones Industrial Average, DuPont, moved in the opposite direction, falling $2.26, or 3.34%, to $65.44 after the industrial conglomerate cut its earnings outlook for its second quarter and its current fiscal year. MAJOR MOVERS: Among the notable gainers was Amedisys (AMED), which rose $4.01, or 29.81%, to $17.46 and was upgraded at CRT Capital after the company gave Q2 guidance. Also higher was Manitowoc (MTW), which gained $3.22, or 10.84%, to $32.93 and was upgraded to Hold at Jefferies after activist Relational Investors took an 8.5% stake in the company and urged for a spin-off of its food business. Among the noteworthy losers was discount retailer Dollar General (DG), which fell $4.49, or 7.28%, to $57.19 after Chief Executive Officer Rick Dreiling announced plans to retire. Also lower were shares of MannKind (MNKD), which dropped 58c, or 5.48%, to $10.00 after the FDA approved its Afrezza inhalation powder to treat diabetes but required the drug to have a Boxed Warning and required the company to conduct several post-marketing studies on the drug. INDEXES: The Dow was up 5.71, or 0.03%, to 16,851.84, the Nasdaq was up 18.88, or 0.43%, to 4,397.93, and the S&P 500 was up 3.74, or 0.19%, to 1,960.96.
News For NKE;DD;FINL;MNKD;MTW;DG;AMED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 10, 2014
16:17 EDTDGDollar General receives second request from FTC
Subscribe for More Information
13:08 EDTMTWOn The Fly: Midday Wrap
Stocks on Wall Street opened in negative territory and saw several swings throughout the morning. Near midday the averages were mixed, with the Dow a bit higher and the Nasdaq weighed down by weakness across the semiconductor sector. ECONOMIC EVENTS: In the U.S., the import price index fell 0.5% in September, versus expectations for a 0.7% decline. COMPANY NEWS: Shares of a number of semiconductor makers, including industry giant Intel (INTC), were sharply lower after one of the companies in the space, Microchip Technology (MCHP), warned that it believes the sector has entered a correction. Microchip President and CEO Steve Sanghi claimed his company often sees the turn of the semiconductor industry ahead of others, noting that it does business with over 80,000 customers and that it built a significant amount of inventory in the distribution channel in the September quarter. Sanghi stated, "We believe that another industry correction has begun and that this correction will be seen more broadly across the industry in the near future.” Near noon, Microchip dropped 11%, Intel fell almost 4%, Texas Instruments (TXN) slipped over 6%, Micron (MU) dropped 6% and Fairchild (FCS) declined 12%. MAJOR MOVERS: Among the notable gainers was Exact Sciences (EXAS), which rallied 35% after the company announced last night that the Centers for Medicare & Medicaid Services, or CMS, had agreed to cover the company's colorectal cancer and pre-cancer test through Medicare. Among the noteworthy losers were a number of companies that, similarly to Microchip, warned that their quarterly results will likely miss expectations, including Procera Networks (PKT), which plunged 34%, Manitowoc (MTW), which fell 9%, and Sizmek (SZMK), which dropped 21%. INDEXES: Near midday, the Dow was up 38.02, or 0.23%, to 16,697.27, the Nasdaq was down 35.89, or 0.82%, to 4,342.45, and the S&P 500 was up 0.42, or 0.02%, to 1,928.63.
12:05 EDTDDUSDA raises U.S. corn production estimate to 14.475B
Subscribe for More Information
10:01 EDTMTWOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:01 EDTDDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:00 EDTMTWOn The Fly: Pre-market Movers
Subscribe for More Information
08:36 EDTMTWManitowoc downgraded at BMO Capital
Subscribe for More Information
08:11 EDTDGFamily Dollar Q4 bad enough to justify merger, says FBR Capital
Subscribe for More Information
06:29 EDTMTWManitowoc downgraded to Underperform from Market Perform at BMO Capital
05:43 EDTDDDuPont upgraded to Buy from Hold at Jefferies
Jefferies upgraded DuPont to Buy citing the pullback in shares and its belief the company's capital return program should sustain low-teens earnings growth. The firm raised its price target for shares to $84 from $72.
October 9, 2014
19:11 EDTMTWManitowoc sees FY14 Crane segment revenues declining
For FY14, Manitowoc now anticipates Crane segment revenues to decline by mid-to-high single-digit percentages compared to FY13 revenues, while it expects Crane operating margins for FY14 to be in the 7% range. In addition, Manitowoc now expects FY14 Foodservice segment revenues to be up by low-to-mid single-digit percentages as compared to revenues for the prior-year period. The company expects this segment’s operating margins for FY14 to be in the 15% range. In addition, the company is adjusting its guidance for end-of-year debt-to-EBITDA to approximately 3.5 times, versus below 3 times previously expected, and is reducing its interest expense guidance to a low-to-mid $90M range. The company is reaffirming the remainder of its full-year outlook: capital expenditures of approximately $90M, depreciation & amortization of approximately $120M, amortization of deferred financing fees of less than $5M, and effective tax rate in the mid-teens percentage range driven by expected Q3 discrete items.
19:06 EDTMTWManitowoc sees Q3 revenue 'just under' $1B, consensus $1.02B
Subscribe for More Information
10:00 EDTDDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:41 EDTDG, NKE, FINLBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
07:20 EDTDDArchitectural Record to hold a conference
Subscribe for More Information
06:10 EDTNKEStocks with implied volatility below IV index mean; NKE LULU
Subscribe for More Information
October 8, 2014
16:29 EDTDDU.S. Chemicals sector initiated with an Overweight at RBC Capital
RBC Capital started the U.S. Chemicals sector with an Overweight rating citing the growth of shale gas. The firm lists ethylene stocks LyondellBasell (LYB), Westlake Chemical (WLK) and Dow Chemical (DOW) its top picks in the space. RBC views coatings stocks as good ways to play the pending recovery in construction, and has Outperform ratings on Sherwin-Williams (SHW) and PPG Industries (PPG). RBC put its only Underperform rating in the sector on Axiall (AXLL), citing the company's short ethylene position and leverage to single-family housing.
16:20 EDTDDDuPont initiated with a Sector Perform at RBC Capital
Target $71.
09:23 EDTFINLCitigroup to hold a tour
Athletic Footwear Mall Tour travels to Roosevelt Field Mall, Garden City, New York on October 8.
05:53 EDTMNKDStocks with implied volatility movement; MNKD AFSI
Stocks with implied volatility movement; MannKind (MNKD) 85, AmTrust Financial (AFSI) 68 according to iVolatility.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use